Intrinsic Value

The intrinsic value of Medipal Holdings Corp (7459) under the Base Case is 3 251.43 JPY per share. Compared with the current market price of 3 170 JPY, the stock appears Undervalued by 3% .

The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 3% a year over the next five years, against 4% over the last five, and operating margin stays near last year's 1.1%.

Do our valuations actually work? See backtest results .

Intrinsic Value
¥3 251.43
Undervaluation 3%
Intrinsic Value
Price ¥3 170

Medipal Holdings Corp is more expensive than usual. Still undervalued, but at its most expensive valuation in the past 5 years.

Monitor Medipal Holdings Corp
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value ¥2 601.15
Get notified when the price drops into your buy zone
Intrinsic Value ¥3 251.43
Current Price ¥3 170
Margin of Safety 20% ¥2 601.15
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to Medipal Holdings Corp

Fundamental Analysis

What Medipal Does

Health Care

Medipal Holdings is a Japanese healthcare distributor. It buys prescription medicines and other healthcare products from drug makers and delivers them to pharmacies, hospitals, and clinics. In simple terms, it sits in the middle of the healthcare supply chain and makes sure the right products reach the right medical sites on time.

Headquarters
Japan JP
Employees
13 061
IPO date
Sep 14, 1995
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Medipal Holdings Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Medipal Holdings Corp stock?

The intrinsic value for Medipal Holdings Corp (7459) under the Base Case is 3 251.43 JPY.

Is Medipal Holdings Corp stock undervalued or overvalued?

Compared with the current market price of 3 170 JPY, the stock appears Undervalued by 3% .

Back to Top